Question

PASSAGE (Questions 1–6): The human retina contains two primary types of photoreceptor cells: rods and cones. Rods, numbering approximately 120 million per retina, are exquisitely sensitive to dim light and are responsible for scotopic (low-light) vision. They are densely packed in the peripheral retina but notably absent from the fovea centralis. Cones, of which there are roughly 6–7 million per retina, are concentrated in the fovea and are responsible for photopic (bright-light) vision and color discrimination. Three subtypes of cones exist—S-cones (short wavelength, sensitive to blue light), M-cones (medium wavelength, sensitive to green light), and L-cones (long wavelength, sensitive to red light)—enabling trichromatic color vision in humans. Phototransduction begins when light strikes a photopigment molecule. In rods, the photopigment is rhodopsin, composed of the protein opsin bound to a light-sensitive chromophore called retinal (a derivative of vitamin A). Absorption of a photon isomerizes retinal from the 11-cis conformation to the all-trans conformation, initiating a G-protein signaling cascade. This activates transducin, which in turn activates phosphodiesterase (PDE). PDE hydrolyzes cyclic GMP (cGMP), lowering its intracellular concentration. Because cGMP normally holds sodium channels open, the reduction in cGMP causes channel closure, hyperpolarizing the cell. This hyperpolarization reduces glutamate release from the photoreceptor's synaptic terminal, signaling the onset of light to downstream bipolar and ganglion cells. The fovea, roughly 1.5 mm in diameter, is the region of highest visual acuity. Its center, the foveola, contains only cones with no overlying retinal neurons—a thinning called the foveal pit—which minimizes light scattering and maximizes resolution. The optic disc, where the optic nerve exits the eye, contains no photoreceptors and corresponds to the physiological blind spot. The neural signals from retinal ganglion cells travel along the optic nerve to the lateral geniculate nucleus (LGN) of the thalamus, then to the primary visual cortex (V1) in the occipital lobe for further processing. Question 1: According to the passage, what direct effect does phototransduction have on the photoreceptor cell's membrane potential?

Reading Comprehension

Question · Easy

Question

PASSAGE (Questions 1–6 — same passage as Q1): The human retina contains two primary types of photoreceptor cells: rods and cones. Rods, numbering approximately 120 million per retina, are exquisitely sensitive to dim light and are responsible for scotopic (low-light) vision. They are densely packed in the peripheral retina but notably absent from the fovea centralis. Cones, of which there are roughly 6–7 million per retina, are concentrated in the fovea and are responsible for photopic (bright-light) vision and color discrimination. Three subtypes of cones exist—S-cones (short wavelength, sensitive to blue light), M-cones (medium wavelength, sensitive to green light), and L-cones (long wavelength, sensitive to red light)—enabling trichromatic color vision in humans. Phototransduction begins when light strikes a photopigment molecule. In rods, the photopigment is rhodopsin, composed of the protein opsin bound to a light-sensitive chromophore called retinal (a derivative of vitamin A). Absorption of a photon isomerizes retinal from the 11-cis conformation to the all-trans conformation, initiating a G-protein signaling cascade. This activates transducin, which in turn activates phosphodiesterase (PDE). PDE hydrolyzes cyclic GMP (cGMP), lowering its intracellular concentration. Because cGMP normally holds sodium channels open, the reduction in cGMP causes channel closure, hyperpolarizing the cell. This hyperpolarization reduces glutamate release from the photoreceptor's synaptic terminal, signaling the onset of light to downstream bipolar and ganglion cells. The fovea, roughly 1.5 mm in diameter, is the region of highest visual acuity. Its center, the foveola, contains only cones with no overlying retinal neurons—a thinning called the foveal pit—which minimizes light scattering and maximizes resolution. The optic disc, where the optic nerve exits the eye, contains no photoreceptors and corresponds to the physiological blind spot. The neural signals from retinal ganglion cells travel along the optic nerve to the lateral geniculate nucleus (LGN) of the thalamus, then to the primary visual cortex (V1) in the occipital lobe for further processing. Question 2: What is the primary purpose of the foveal pit as described in the passage?

Reading Comprehension

Question · Easy

Question

PASSAGE (Questions 1–6 — same passage as Q1): The human retina contains two primary types of photoreceptor cells: rods and cones. Rods, numbering approximately 120 million per retina, are exquisitely sensitive to dim light and are responsible for scotopic (low-light) vision. They are densely packed in the peripheral retina but notably absent from the fovea centralis. Cones, of which there are roughly 6–7 million per retina, are concentrated in the fovea and are responsible for photopic (bright-light) vision and color discrimination. Three subtypes of cones exist—S-cones (short wavelength, sensitive to blue light), M-cones (medium wavelength, sensitive to green light), and L-cones (long wavelength, sensitive to red light)—enabling trichromatic color vision in humans. Phototransduction begins when light strikes a photopigment molecule. In rods, the photopigment is rhodopsin, composed of the protein opsin bound to a light-sensitive chromophore called retinal (a derivative of vitamin A). Absorption of a photon isomerizes retinal from the 11-cis conformation to the all-trans conformation, initiating a G-protein signaling cascade. This activates transducin, which in turn activates phosphodiesterase (PDE). PDE hydrolyzes cyclic GMP (cGMP), lowering its intracellular concentration. Because cGMP normally holds sodium channels open, the reduction in cGMP causes channel closure, hyperpolarizing the cell. This hyperpolarization reduces glutamate release from the photoreceptor's synaptic terminal, signaling the onset of light to downstream bipolar and ganglion cells. The fovea, roughly 1.5 mm in diameter, is the region of highest visual acuity. Its center, the foveola, contains only cones with no overlying retinal neurons—a thinning called the foveal pit—which minimizes light scattering and maximizes resolution. The optic disc, where the optic nerve exits the eye, contains no photoreceptors and corresponds to the physiological blind spot. The neural signals from retinal ganglion cells travel along the optic nerve to the lateral geniculate nucleus (LGN) of the thalamus, then to the primary visual cortex (V1) in the occipital lobe for further processing. Question 3: Based on the passage, a person with a severe vitamin A deficiency would MOST likely experience difficulty with which of the following?

Reading Comprehension

Question · Medium

Question

PASSAGE (Questions 1–6 — same passage as Q1): The human retina contains two primary types of photoreceptor cells: rods and cones. Rods, numbering approximately 120 million per retina, are exquisitely sensitive to dim light and are responsible for scotopic (low-light) vision. They are densely packed in the peripheral retina but notably absent from the fovea centralis. Cones, of which there are roughly 6–7 million per retina, are concentrated in the fovea and are responsible for photopic (bright-light) vision and color discrimination. Three subtypes of cones exist—S-cones (short wavelength, sensitive to blue light), M-cones (medium wavelength, sensitive to green light), and L-cones (long wavelength, sensitive to red light)—enabling trichromatic color vision in humans. Phototransduction begins when light strikes a photopigment molecule. In rods, the photopigment is rhodopsin, composed of the protein opsin bound to a light-sensitive chromophore called retinal (a derivative of vitamin A). Absorption of a photon isomerizes retinal from the 11-cis conformation to the all-trans conformation, initiating a G-protein signaling cascade. This activates transducin, which in turn activates phosphodiesterase (PDE). PDE hydrolyzes cyclic GMP (cGMP), lowering its intracellular concentration. Because cGMP normally holds sodium channels open, the reduction in cGMP causes channel closure, hyperpolarizing the cell. This hyperpolarization reduces glutamate release from the photoreceptor's synaptic terminal, signaling the onset of light to downstream bipolar and ganglion cells. The fovea, roughly 1.5 mm in diameter, is the region of highest visual acuity. Its center, the foveola, contains only cones with no overlying retinal neurons—a thinning called the foveal pit—which minimizes light scattering and maximizes resolution. The optic disc, where the optic nerve exits the eye, contains no photoreceptors and corresponds to the physiological blind spot. The neural signals from retinal ganglion cells travel along the optic nerve to the lateral geniculate nucleus (LGN) of the thalamus, then to the primary visual cortex (V1) in the occipital lobe for further processing. Question 4: Which of the following best describes the main idea of the passage?

Reading Comprehension

Question · Easy

Question

PASSAGE (Questions 1–6 — same passage as Q1): The human retina contains two primary types of photoreceptor cells: rods and cones. Rods, numbering approximately 120 million per retina, are exquisitely sensitive to dim light and are responsible for scotopic (low-light) vision. They are densely packed in the peripheral retina but notably absent from the fovea centralis. Cones, of which there are roughly 6–7 million per retina, are concentrated in the fovea and are responsible for photopic (bright-light) vision and color discrimination. Three subtypes of cones exist—S-cones (short wavelength, sensitive to blue light), M-cones (medium wavelength, sensitive to green light), and L-cones (long wavelength, sensitive to red light)—enabling trichromatic color vision in humans. Phototransduction begins when light strikes a photopigment molecule. In rods, the photopigment is rhodopsin, composed of the protein opsin bound to a light-sensitive chromophore called retinal (a derivative of vitamin A). Absorption of a photon isomerizes retinal from the 11-cis conformation to the all-trans conformation, initiating a G-protein signaling cascade. This activates transducin, which in turn activates phosphodiesterase (PDE). PDE hydrolyzes cyclic GMP (cGMP), lowering its intracellular concentration. Because cGMP normally holds sodium channels open, the reduction in cGMP causes channel closure, hyperpolarizing the cell. This hyperpolarization reduces glutamate release from the photoreceptor's synaptic terminal, signaling the onset of light to downstream bipolar and ganglion cells. The fovea, roughly 1.5 mm in diameter, is the region of highest visual acuity. Its center, the foveola, contains only cones with no overlying retinal neurons—a thinning called the foveal pit—which minimizes light scattering and maximizes resolution. The optic disc, where the optic nerve exits the eye, contains no photoreceptors and corresponds to the physiological blind spot. The neural signals from retinal ganglion cells travel along the optic nerve to the lateral geniculate nucleus (LGN) of the thalamus, then to the primary visual cortex (V1) in the occipital lobe for further processing. Question 5: As used in the passage, the term 'chromophore' most nearly means:

Reading Comprehension

Question · Medium

Question

PASSAGE (Questions 1–6 — same passage as Q1): The human retina contains two primary types of photoreceptor cells: rods and cones. Rods, numbering approximately 120 million per retina, are exquisitely sensitive to dim light and are responsible for scotopic (low-light) vision. They are densely packed in the peripheral retina but notably absent from the fovea centralis. Cones, of which there are roughly 6–7 million per retina, are concentrated in the fovea and are responsible for photopic (bright-light) vision and color discrimination. Three subtypes of cones exist—S-cones (short wavelength, sensitive to blue light), M-cones (medium wavelength, sensitive to green light), and L-cones (long wavelength, sensitive to red light)—enabling trichromatic color vision in humans. Phototransduction begins when light strikes a photopigment molecule. In rods, the photopigment is rhodopsin, composed of the protein opsin bound to a light-sensitive chromophore called retinal (a derivative of vitamin A). Absorption of a photon isomerizes retinal from the 11-cis conformation to the all-trans conformation, initiating a G-protein signaling cascade. This activates transducin, which in turn activates phosphodiesterase (PDE). PDE hydrolyzes cyclic GMP (cGMP), lowering its intracellular concentration. Because cGMP normally holds sodium channels open, the reduction in cGMP causes channel closure, hyperpolarizing the cell. This hyperpolarization reduces glutamate release from the photoreceptor's synaptic terminal, signaling the onset of light to downstream bipolar and ganglion cells. The fovea, roughly 1.5 mm in diameter, is the region of highest visual acuity. Its center, the foveola, contains only cones with no overlying retinal neurons—a thinning called the foveal pit—which minimizes light scattering and maximizes resolution. The optic disc, where the optic nerve exits the eye, contains no photoreceptors and corresponds to the physiological blind spot. The neural signals from retinal ganglion cells travel along the optic nerve to the lateral geniculate nucleus (LGN) of the thalamus, then to the primary visual cortex (V1) in the occipital lobe for further processing. Question 6: The author organizes the passage primarily by:

Reading Comprehension

Question · Medium

Question

PASSAGE (Questions 7–13): Glucose metabolism is central to cellular energy production. In glycolysis, a molecule of glucose (a six-carbon sugar) is split into two molecules of pyruvate (three carbons each) in the cytosol, yielding a net gain of 2 ATP and 2 NADH per glucose. Glycolysis proceeds through ten enzyme-catalyzed steps. The first is glucose phosphorylation by hexokinase, consuming one ATP to produce glucose-6-phosphate (G6P). G6P cannot cross the plasma membrane, effectively trapping glucose inside the cell. A second ATP is consumed later in the process when fructose-6-phosphate is converted to fructose-1,6-bisphosphate by phosphofructokinase-1 (PFK-1), the primary regulatory step. PFK-1 is allosterically inhibited by high concentrations of ATP and citrate (signals of energy sufficiency) and activated by AMP and fructose-2,6-bisphosphate. Under aerobic conditions, pyruvate enters the mitochondrial matrix, where it is oxidatively decarboxylated by the pyruvate dehydrogenase complex (PDC) to form acetyl-CoA, releasing one CO2 and one NADH per pyruvate. Acetyl-CoA then enters the citric acid cycle (Krebs cycle), where it is completely oxidized over eight steps, generating per acetyl-CoA: 3 NADH, 1 FADH2, and 1 GTP (equivalent to 1 ATP). The high-energy electrons carried by NADH and FADH2 are donated to the electron transport chain (ETC) on the inner mitochondrial membrane. As electrons flow through Complexes I–IV, protons are pumped from the matrix to the intermembrane space, creating a proton-motive force. ATP synthase (Complex V) harnesses this force to synthesize ATP from ADP and inorganic phosphate (Pi)—a process called oxidative phosphorylation. Under anaerobic conditions—when oxygen is absent or insufficient—cells regenerate NAD+ from NADH via fermentation. In animals and many bacteria, pyruvate is reduced to lactate by lactate dehydrogenase (LDH), reoxidizing NADH to NAD+. This allows glycolysis to continue producing ATP even without oxygen, albeit at a much lower yield (2 ATP per glucose compared to approximately 30–32 ATP under full aerobic conditions). In yeast, fermentation produces ethanol and CO2 instead of lactate. The switch between aerobic and anaerobic metabolism is regulated by oxygen availability and the cellular energy charge. Question 7: According to the passage, what is the primary function of PFK-1 in glycolysis?

Reading Comprehension

Question · Easy

Question

PASSAGE (Questions 7–13 — same passage as Q7): Glucose metabolism is central to cellular energy production. In glycolysis, a molecule of glucose (a six-carbon sugar) is split into two molecules of pyruvate (three carbons each) in the cytosol, yielding a net gain of 2 ATP and 2 NADH per glucose. Glycolysis proceeds through ten enzyme-catalyzed steps. The first is glucose phosphorylation by hexokinase, consuming one ATP to produce glucose-6-phosphate (G6P). G6P cannot cross the plasma membrane, effectively trapping glucose inside the cell. A second ATP is consumed later in the process when fructose-6-phosphate is converted to fructose-1,6-bisphosphate by phosphofructokinase-1 (PFK-1), the primary regulatory step. PFK-1 is allosterically inhibited by high concentrations of ATP and citrate (signals of energy sufficiency) and activated by AMP and fructose-2,6-bisphosphate. Under aerobic conditions, pyruvate enters the mitochondrial matrix, where it is oxidatively decarboxylated by the pyruvate dehydrogenase complex (PDC) to form acetyl-CoA, releasing one CO2 and one NADH per pyruvate. Acetyl-CoA then enters the citric acid cycle (Krebs cycle), where it is completely oxidized over eight steps, generating per acetyl-CoA: 3 NADH, 1 FADH2, and 1 GTP (equivalent to 1 ATP). The high-energy electrons carried by NADH and FADH2 are donated to the electron transport chain (ETC) on the inner mitochondrial membrane. As electrons flow through Complexes I–IV, protons are pumped from the matrix to the intermembrane space, creating a proton-motive force. ATP synthase (Complex V) harnesses this force to synthesize ATP from ADP and inorganic phosphate (Pi)—a process called oxidative phosphorylation. Under anaerobic conditions—when oxygen is absent or insufficient—cells regenerate NAD+ from NADH via fermentation. In animals and many bacteria, pyruvate is reduced to lactate by lactate dehydrogenase (LDH), reoxidizing NADH to NAD+. This allows glycolysis to continue producing ATP even without oxygen, albeit at a much lower yield (2 ATP per glucose compared to approximately 30–32 ATP under full aerobic conditions). In yeast, fermentation produces ethanol and CO2 instead of lactate. The switch between aerobic and anaerobic metabolism is regulated by oxygen availability and the cellular energy charge. Question 8: Which of the following conditions, according to the passage, would INHIBIT PFK-1 activity?

Reading Comprehension

Question · Easy

Question

PASSAGE (Questions 7–13 — same passage as Q7): Glucose metabolism is central to cellular energy production. In glycolysis, a molecule of glucose (a six-carbon sugar) is split into two molecules of pyruvate (three carbons each) in the cytosol, yielding a net gain of 2 ATP and 2 NADH per glucose. Glycolysis proceeds through ten enzyme-catalyzed steps. The first is glucose phosphorylation by hexokinase, consuming one ATP to produce glucose-6-phosphate (G6P). G6P cannot cross the plasma membrane, effectively trapping glucose inside the cell. A second ATP is consumed later in the process when fructose-6-phosphate is converted to fructose-1,6-bisphosphate by phosphofructokinase-1 (PFK-1), the primary regulatory step. PFK-1 is allosterically inhibited by high concentrations of ATP and citrate (signals of energy sufficiency) and activated by AMP and fructose-2,6-bisphosphate. Under aerobic conditions, pyruvate enters the mitochondrial matrix, where it is oxidatively decarboxylated by the pyruvate dehydrogenase complex (PDC) to form acetyl-CoA, releasing one CO2 and one NADH per pyruvate. Acetyl-CoA then enters the citric acid cycle (Krebs cycle), where it is completely oxidized over eight steps, generating per acetyl-CoA: 3 NADH, 1 FADH2, and 1 GTP (equivalent to 1 ATP). The high-energy electrons carried by NADH and FADH2 are donated to the electron transport chain (ETC) on the inner mitochondrial membrane. As electrons flow through Complexes I–IV, protons are pumped from the matrix to the intermembrane space, creating a proton-motive force. ATP synthase (Complex V) harnesses this force to synthesize ATP from ADP and inorganic phosphate (Pi)—a process called oxidative phosphorylation. Under anaerobic conditions—when oxygen is absent or insufficient—cells regenerate NAD+ from NADH via fermentation. In animals and many bacteria, pyruvate is reduced to lactate by lactate dehydrogenase (LDH), reoxidizing NADH to NAD+. This allows glycolysis to continue producing ATP even without oxygen, albeit at a much lower yield (2 ATP per glucose compared to approximately 30–32 ATP under full aerobic conditions). In yeast, fermentation produces ethanol and CO2 instead of lactate. The switch between aerobic and anaerobic metabolism is regulated by oxygen availability and the cellular energy charge. Question 9: The passage implies that the regeneration of NAD+ during anaerobic fermentation is essential because:

Reading Comprehension

Question · Medium

Question

PASSAGE (Questions 7–13 — same passage as Q7): Glucose metabolism is central to cellular energy production. In glycolysis, a molecule of glucose (a six-carbon sugar) is split into two molecules of pyruvate (three carbons each) in the cytosol, yielding a net gain of 2 ATP and 2 NADH per glucose. Glycolysis proceeds through ten enzyme-catalyzed steps. The first is glucose phosphorylation by hexokinase, consuming one ATP to produce glucose-6-phosphate (G6P). G6P cannot cross the plasma membrane, effectively trapping glucose inside the cell. A second ATP is consumed later in the process when fructose-6-phosphate is converted to fructose-1,6-bisphosphate by phosphofructokinase-1 (PFK-1), the primary regulatory step. PFK-1 is allosterically inhibited by high concentrations of ATP and citrate (signals of energy sufficiency) and activated by AMP and fructose-2,6-bisphosphate. Under aerobic conditions, pyruvate enters the mitochondrial matrix, where it is oxidatively decarboxylated by the pyruvate dehydrogenase complex (PDC) to form acetyl-CoA, releasing one CO2 and one NADH per pyruvate. Acetyl-CoA then enters the citric acid cycle (Krebs cycle), where it is completely oxidized over eight steps, generating per acetyl-CoA: 3 NADH, 1 FADH2, and 1 GTP (equivalent to 1 ATP). The high-energy electrons carried by NADH and FADH2 are donated to the electron transport chain (ETC) on the inner mitochondrial membrane. As electrons flow through Complexes I–IV, protons are pumped from the matrix to the intermembrane space, creating a proton-motive force. ATP synthase (Complex V) harnesses this force to synthesize ATP from ADP and inorganic phosphate (Pi)—a process called oxidative phosphorylation. Under anaerobic conditions—when oxygen is absent or insufficient—cells regenerate NAD+ from NADH via fermentation. In animals and many bacteria, pyruvate is reduced to lactate by lactate dehydrogenase (LDH), reoxidizing NADH to NAD+. This allows glycolysis to continue producing ATP even without oxygen, albeit at a much lower yield (2 ATP per glucose compared to approximately 30–32 ATP under full aerobic conditions). In yeast, fermentation produces ethanol and CO2 instead of lactate. The switch between aerobic and anaerobic metabolism is regulated by oxygen availability and the cellular energy charge. Question 10: How many total NADH molecules are produced per glucose molecule through glycolysis AND the pyruvate dehydrogenase step combined (considering both pyruvates from one glucose)?

Reading Comprehension

Question · Medium

Question

PASSAGE (Questions 7–13 — same passage as Q7): Glucose metabolism is central to cellular energy production. In glycolysis, a molecule of glucose (a six-carbon sugar) is split into two molecules of pyruvate (three carbons each) in the cytosol, yielding a net gain of 2 ATP and 2 NADH per glucose. Glycolysis proceeds through ten enzyme-catalyzed steps. The first is glucose phosphorylation by hexokinase, consuming one ATP to produce glucose-6-phosphate (G6P). G6P cannot cross the plasma membrane, effectively trapping glucose inside the cell. A second ATP is consumed later in the process when fructose-6-phosphate is converted to fructose-1,6-bisphosphate by phosphofructokinase-1 (PFK-1), the primary regulatory step. PFK-1 is allosterically inhibited by high concentrations of ATP and citrate (signals of energy sufficiency) and activated by AMP and fructose-2,6-bisphosphate. Under aerobic conditions, pyruvate enters the mitochondrial matrix, where it is oxidatively decarboxylated by the pyruvate dehydrogenase complex (PDC) to form acetyl-CoA, releasing one CO2 and one NADH per pyruvate. Acetyl-CoA then enters the citric acid cycle (Krebs cycle), where it is completely oxidized over eight steps, generating per acetyl-CoA: 3 NADH, 1 FADH2, and 1 GTP (equivalent to 1 ATP). The high-energy electrons carried by NADH and FADH2 are donated to the electron transport chain (ETC) on the inner mitochondrial membrane. As electrons flow through Complexes I–IV, protons are pumped from the matrix to the intermembrane space, creating a proton-motive force. ATP synthase (Complex V) harnesses this force to synthesize ATP from ADP and inorganic phosphate (Pi)—a process called oxidative phosphorylation. Under anaerobic conditions—when oxygen is absent or insufficient—cells regenerate NAD+ from NADH via fermentation. In animals and many bacteria, pyruvate is reduced to lactate by lactate dehydrogenase (LDH), reoxidizing NADH to NAD+. This allows glycolysis to continue producing ATP even without oxygen, albeit at a much lower yield (2 ATP per glucose compared to approximately 30–32 ATP under full aerobic conditions). In yeast, fermentation produces ethanol and CO2 instead of lactate. The switch between aerobic and anaerobic metabolism is regulated by oxygen availability and the cellular energy charge. Question 11: The passage's description of the proton-motive force suggests that ATP synthase functions analogously to which of the following devices?

Reading Comprehension

Question · Hard

Question

PASSAGE (Questions 7–13 — same passage as Q7): Glucose metabolism is central to cellular energy production. In glycolysis, a molecule of glucose (a six-carbon sugar) is split into two molecules of pyruvate (three carbons each) in the cytosol, yielding a net gain of 2 ATP and 2 NADH per glucose. Glycolysis proceeds through ten enzyme-catalyzed steps. The first is glucose phosphorylation by hexokinase, consuming one ATP to produce glucose-6-phosphate (G6P). G6P cannot cross the plasma membrane, effectively trapping glucose inside the cell. A second ATP is consumed later in the process when fructose-6-phosphate is converted to fructose-1,6-bisphosphate by phosphofructokinase-1 (PFK-1), the primary regulatory step. PFK-1 is allosterically inhibited by high concentrations of ATP and citrate (signals of energy sufficiency) and activated by AMP and fructose-2,6-bisphosphate. Under aerobic conditions, pyruvate enters the mitochondrial matrix, where it is oxidatively decarboxylated by the pyruvate dehydrogenase complex (PDC) to form acetyl-CoA, releasing one CO2 and one NADH per pyruvate. Acetyl-CoA then enters the citric acid cycle (Krebs cycle), where it is completely oxidized over eight steps, generating per acetyl-CoA: 3 NADH, 1 FADH2, and 1 GTP (equivalent to 1 ATP). The high-energy electrons carried by NADH and FADH2 are donated to the electron transport chain (ETC) on the inner mitochondrial membrane. As electrons flow through Complexes I–IV, protons are pumped from the matrix to the intermembrane space, creating a proton-motive force. ATP synthase (Complex V) harnesses this force to synthesize ATP from ADP and inorganic phosphate (Pi)—a process called oxidative phosphorylation. Under anaerobic conditions—when oxygen is absent or insufficient—cells regenerate NAD+ from NADH via fermentation. In animals and many bacteria, pyruvate is reduced to lactate by lactate dehydrogenase (LDH), reoxidizing NADH to NAD+. This allows glycolysis to continue producing ATP even without oxygen, albeit at a much lower yield (2 ATP per glucose compared to approximately 30–32 ATP under full aerobic conditions). In yeast, fermentation produces ethanol and CO2 instead of lactate. The switch between aerobic and anaerobic metabolism is regulated by oxygen availability and the cellular energy charge. Question 12: According to the passage, which statement about the location of glycolysis is correct?

Reading Comprehension

Question · Easy

Question

PASSAGE (Questions 7–13 — same passage as Q7): Glucose metabolism is central to cellular energy production. In glycolysis, a molecule of glucose (a six-carbon sugar) is split into two molecules of pyruvate (three carbons each) in the cytosol, yielding a net gain of 2 ATP and 2 NADH per glucose. Glycolysis proceeds through ten enzyme-catalyzed steps. The first is glucose phosphorylation by hexokinase, consuming one ATP to produce glucose-6-phosphate (G6P). G6P cannot cross the plasma membrane, effectively trapping glucose inside the cell. A second ATP is consumed later in the process when fructose-6-phosphate is converted to fructose-1,6-bisphosphate by phosphofructokinase-1 (PFK-1), the primary regulatory step. PFK-1 is allosterically inhibited by high concentrations of ATP and citrate (signals of energy sufficiency) and activated by AMP and fructose-2,6-bisphosphate. Under aerobic conditions, pyruvate enters the mitochondrial matrix, where it is oxidatively decarboxylated by the pyruvate dehydrogenase complex (PDC) to form acetyl-CoA, releasing one CO2 and one NADH per pyruvate. Acetyl-CoA then enters the citric acid cycle (Krebs cycle), where it is completely oxidized over eight steps, generating per acetyl-CoA: 3 NADH, 1 FADH2, and 1 GTP (equivalent to 1 ATP). The high-energy electrons carried by NADH and FADH2 are donated to the electron transport chain (ETC) on the inner mitochondrial membrane. As electrons flow through Complexes I–IV, protons are pumped from the matrix to the intermembrane space, creating a proton-motive force. ATP synthase (Complex V) harnesses this force to synthesize ATP from ADP and inorganic phosphate (Pi)—a process called oxidative phosphorylation. Under anaerobic conditions—when oxygen is absent or insufficient—cells regenerate NAD+ from NADH via fermentation. In animals and many bacteria, pyruvate is reduced to lactate by lactate dehydrogenase (LDH), reoxidizing NADH to NAD+. This allows glycolysis to continue producing ATP even without oxygen, albeit at a much lower yield (2 ATP per glucose compared to approximately 30–32 ATP under full aerobic conditions). In yeast, fermentation produces ethanol and CO2 instead of lactate. The switch between aerobic and anaerobic metabolism is regulated by oxygen availability and the cellular energy charge. Question 13: The author's attitude toward the aerobic pathway compared to anaerobic fermentation can best be described as:

Reading Comprehension

Question · Medium

Question

PASSAGE (Questions 14–20): Acid-base chemistry is foundational to understanding biological and industrial systems. An acid is a proton donor (Brønsted-Lowry definition) or electron-pair acceptor (Lewis definition), while a base is a proton acceptor or electron-pair donor. In aqueous solution, the strength of an acid is quantified by its acid dissociation constant, Ka: for the reaction HA ⇌ H+ + A−, Ka = [H+][A−]/[HA]. A strong acid dissociates nearly completely (Ka >> 1), whereas a weak acid only partially dissociates (Ka << 1). The pH of a solution is defined as pH = −log[H+]; the pKa of an acid is defined as pKa = −log(Ka). A lower pKa indicates a stronger acid. Buffer solutions resist changes in pH upon the addition of small amounts of acid or base. A buffer consists of a weak acid and its conjugate base (or a weak base and its conjugate acid) in solution. The Henderson-Hasselbalch equation describes the relationship: pH = pKa + log([A−]/[HA]), where [A−] is the conjugate base concentration and [HA] is the weak acid concentration. A buffer has its maximum capacity—the ability to neutralize added acid or base—when pH = pKa, i.e., when [A−] = [HA]. Effective buffering occurs within approximately ±1 pH unit of the pKa. Blood plasma is maintained at pH 7.35–7.45 by three main buffer systems: the bicarbonate buffer (H2CO3/HCO3−, pKa ≈ 6.1), the phosphate buffer (H2PO4−/HPO4 2−, pKa ≈ 7.2), and plasma proteins (particularly hemoglobin). Although the bicarbonate buffer's pKa of 6.1 is almost a full pH unit below physiological pH (7.4), it is the most physiologically important because the lungs and kidneys can rapidly adjust CO2 and HCO3− concentrations, respectively, providing dynamic control. The respiratory system compensates for acid-base disturbances within minutes, while renal compensation takes hours to days. Question 14: According to the passage, what is the definition of pKa?

Reading Comprehension

Question · Easy

Question

PASSAGE (Questions 14–20 — same passage as Q14): Acid-base chemistry is foundational to understanding biological and industrial systems. An acid is a proton donor (Brønsted-Lowry definition) or electron-pair acceptor (Lewis definition), while a base is a proton acceptor or electron-pair donor. In aqueous solution, the strength of an acid is quantified by its acid dissociation constant, Ka: for the reaction HA ⇌ H+ + A−, Ka = [H+][A−]/[HA]. A strong acid dissociates nearly completely (Ka >> 1), whereas a weak acid only partially dissociates (Ka << 1). The pH of a solution is defined as pH = −log[H+]; the pKa of an acid is defined as pKa = −log(Ka). A lower pKa indicates a stronger acid. Buffer solutions resist changes in pH upon the addition of small amounts of acid or base. A buffer consists of a weak acid and its conjugate base (or a weak base and its conjugate acid) in solution. The Henderson-Hasselbalch equation describes the relationship: pH = pKa + log([A−]/[HA]), where [A−] is the conjugate base concentration and [HA] is the weak acid concentration. A buffer has its maximum capacity—the ability to neutralize added acid or base—when pH = pKa, i.e., when [A−] = [HA]. Effective buffering occurs within approximately ±1 pH unit of the pKa. Blood plasma is maintained at pH 7.35–7.45 by three main buffer systems: the bicarbonate buffer (H2CO3/HCO3−, pKa ≈ 6.1), the phosphate buffer (H2PO4−/HPO4 2−, pKa ≈ 7.2), and plasma proteins (particularly hemoglobin). Although the bicarbonate buffer's pKa of 6.1 is almost a full pH unit below physiological pH (7.4), it is the most physiologically important because the lungs and kidneys can rapidly adjust CO2 and HCO3− concentrations, respectively, providing dynamic control. The respiratory system compensates for acid-base disturbances within minutes, while renal compensation takes hours to days. Question 15: A buffer made from a weak acid with pKa = 7.2 would be MOST effective at buffering which of the following pH values?

Reading Comprehension

Question · Easy

Question

PASSAGE (Questions 14–20 — same passage as Q14): Acid-base chemistry is foundational to understanding biological and industrial systems. An acid is a proton donor (Brønsted-Lowry definition) or electron-pair acceptor (Lewis definition), while a base is a proton acceptor or electron-pair donor. In aqueous solution, the strength of an acid is quantified by its acid dissociation constant, Ka: for the reaction HA ⇌ H+ + A−, Ka = [H+][A−]/[HA]. A strong acid dissociates nearly completely (Ka >> 1), whereas a weak acid only partially dissociates (Ka << 1). The pH of a solution is defined as pH = −log[H+]; the pKa of an acid is defined as pKa = −log(Ka). A lower pKa indicates a stronger acid. Buffer solutions resist changes in pH upon the addition of small amounts of acid or base. A buffer consists of a weak acid and its conjugate base (or a weak base and its conjugate acid) in solution. The Henderson-Hasselbalch equation describes the relationship: pH = pKa + log([A−]/[HA]), where [A−] is the conjugate base concentration and [HA] is the weak acid concentration. A buffer has its maximum capacity—the ability to neutralize added acid or base—when pH = pKa, i.e., when [A−] = [HA]. Effective buffering occurs within approximately ±1 pH unit of the pKa. Blood plasma is maintained at pH 7.35–7.45 by three main buffer systems: the bicarbonate buffer (H2CO3/HCO3−, pKa ≈ 6.1), the phosphate buffer (H2PO4−/HPO4 2−, pKa ≈ 7.2), and plasma proteins (particularly hemoglobin). Although the bicarbonate buffer's pKa of 6.1 is almost a full pH unit below physiological pH (7.4), it is the most physiologically important because the lungs and kidneys can rapidly adjust CO2 and HCO3− concentrations, respectively, providing dynamic control. The respiratory system compensates for acid-base disturbances within minutes, while renal compensation takes hours to days. Question 16: The passage implies that if the kidneys fail to regulate HCO3−, acid-base compensation would be:

Reading Comprehension

Question · Medium

Question

PASSAGE (Questions 14–20 — same passage as Q14): Acid-base chemistry is foundational to understanding biological and industrial systems. An acid is a proton donor (Brønsted-Lowry definition) or electron-pair acceptor (Lewis definition), while a base is a proton acceptor or electron-pair donor. In aqueous solution, the strength of an acid is quantified by its acid dissociation constant, Ka: for the reaction HA ⇌ H+ + A−, Ka = [H+][A−]/[HA]. A strong acid dissociates nearly completely (Ka >> 1), whereas a weak acid only partially dissociates (Ka << 1). The pH of a solution is defined as pH = −log[H+]; the pKa of an acid is defined as pKa = −log(Ka). A lower pKa indicates a stronger acid. Buffer solutions resist changes in pH upon the addition of small amounts of acid or base. A buffer consists of a weak acid and its conjugate base (or a weak base and its conjugate acid) in solution. The Henderson-Hasselbalch equation describes the relationship: pH = pKa + log([A−]/[HA]), where [A−] is the conjugate base concentration and [HA] is the weak acid concentration. A buffer has its maximum capacity—the ability to neutralize added acid or base—when pH = pKa, i.e., when [A−] = [HA]. Effective buffering occurs within approximately ±1 pH unit of the pKa. Blood plasma is maintained at pH 7.35–7.45 by three main buffer systems: the bicarbonate buffer (H2CO3/HCO3−, pKa ≈ 6.1), the phosphate buffer (H2PO4−/HPO4 2−, pKa ≈ 7.2), and plasma proteins (particularly hemoglobin). Although the bicarbonate buffer's pKa of 6.1 is almost a full pH unit below physiological pH (7.4), it is the most physiologically important because the lungs and kidneys can rapidly adjust CO2 and HCO3− concentrations, respectively, providing dynamic control. The respiratory system compensates for acid-base disturbances within minutes, while renal compensation takes hours to days. Question 17: As used in the passage, the word 'dynamic' in 'providing dynamic control' most nearly means:

Reading Comprehension

Question · Medium

Question

PASSAGE (Questions 14–20 — same passage as Q14): Acid-base chemistry is foundational to understanding biological and industrial systems. An acid is a proton donor (Brønsted-Lowry definition) or electron-pair acceptor (Lewis definition), while a base is a proton acceptor or electron-pair donor. In aqueous solution, the strength of an acid is quantified by its acid dissociation constant, Ka: for the reaction HA ⇌ H+ + A−, Ka = [H+][A−]/[HA]. A strong acid dissociates nearly completely (Ka >> 1), whereas a weak acid only partially dissociates (Ka << 1). The pH of a solution is defined as pH = −log[H+]; the pKa of an acid is defined as pKa = −log(Ka). A lower pKa indicates a stronger acid. Buffer solutions resist changes in pH upon the addition of small amounts of acid or base. A buffer consists of a weak acid and its conjugate base (or a weak base and its conjugate acid) in solution. The Henderson-Hasselbalch equation describes the relationship: pH = pKa + log([A−]/[HA]), where [A−] is the conjugate base concentration and [HA] is the weak acid concentration. A buffer has its maximum capacity—the ability to neutralize added acid or base—when pH = pKa, i.e., when [A−] = [HA]. Effective buffering occurs within approximately ±1 pH unit of the pKa. Blood plasma is maintained at pH 7.35–7.45 by three main buffer systems: the bicarbonate buffer (H2CO3/HCO3−, pKa ≈ 6.1), the phosphate buffer (H2PO4−/HPO4 2−, pKa ≈ 7.2), and plasma proteins (particularly hemoglobin). Although the bicarbonate buffer's pKa of 6.1 is almost a full pH unit below physiological pH (7.4), it is the most physiologically important because the lungs and kidneys can rapidly adjust CO2 and HCO3− concentrations, respectively, providing dynamic control. The respiratory system compensates for acid-base disturbances within minutes, while renal compensation takes hours to days. Question 18: Which of the following best expresses the main argument of the third paragraph?

Reading Comprehension

Question · Medium

Question

PASSAGE (Questions 14–20 — same passage as Q14): Acid-base chemistry is foundational to understanding biological and industrial systems. An acid is a proton donor (Brønsted-Lowry definition) or electron-pair acceptor (Lewis definition), while a base is a proton acceptor or electron-pair donor. In aqueous solution, the strength of an acid is quantified by its acid dissociation constant, Ka: for the reaction HA ⇌ H+ + A−, Ka = [H+][A−]/[HA]. A strong acid dissociates nearly completely (Ka >> 1), whereas a weak acid only partially dissociates (Ka << 1). The pH of a solution is defined as pH = −log[H+]; the pKa of an acid is defined as pKa = −log(Ka). A lower pKa indicates a stronger acid. Buffer solutions resist changes in pH upon the addition of small amounts of acid or base. A buffer consists of a weak acid and its conjugate base (or a weak base and its conjugate acid) in solution. The Henderson-Hasselbalch equation describes the relationship: pH = pKa + log([A−]/[HA]), where [A−] is the conjugate base concentration and [HA] is the weak acid concentration. A buffer has its maximum capacity—the ability to neutralize added acid or base—when pH = pKa, i.e., when [A−] = [HA]. Effective buffering occurs within approximately ±1 pH unit of the pKa. Blood plasma is maintained at pH 7.35–7.45 by three main buffer systems: the bicarbonate buffer (H2CO3/HCO3−, pKa ≈ 6.1), the phosphate buffer (H2PO4−/HPO4 2−, pKa ≈ 7.2), and plasma proteins (particularly hemoglobin). Although the bicarbonate buffer's pKa of 6.1 is almost a full pH unit below physiological pH (7.4), it is the most physiologically important because the lungs and kidneys can rapidly adjust CO2 and HCO3− concentrations, respectively, providing dynamic control. The respiratory system compensates for acid-base disturbances within minutes, while renal compensation takes hours to days. Question 19: Which of the following logical structures does the third paragraph use to make its point?

Reading Comprehension

Question · Hard

Question

PASSAGE (Questions 14–20 — same passage as Q14): Acid-base chemistry is foundational to understanding biological and industrial systems. An acid is a proton donor (Brønsted-Lowry definition) or electron-pair acceptor (Lewis definition), while a base is a proton acceptor or electron-pair donor. In aqueous solution, the strength of an acid is quantified by its acid dissociation constant, Ka: for the reaction HA ⇌ H+ + A−, Ka = [H+][A−]/[HA]. A strong acid dissociates nearly completely (Ka >> 1), whereas a weak acid only partially dissociates (Ka << 1). The pH of a solution is defined as pH = −log[H+]; the pKa of an acid is defined as pKa = −log(Ka). A lower pKa indicates a stronger acid. Buffer solutions resist changes in pH upon the addition of small amounts of acid or base. A buffer consists of a weak acid and its conjugate base (or a weak base and its conjugate acid) in solution. The Henderson-Hasselbalch equation describes the relationship: pH = pKa + log([A−]/[HA]), where [A−] is the conjugate base concentration and [HA] is the weak acid concentration. A buffer has its maximum capacity—the ability to neutralize added acid or base—when pH = pKa, i.e., when [A−] = [HA]. Effective buffering occurs within approximately ±1 pH unit of the pKa. Blood plasma is maintained at pH 7.35–7.45 by three main buffer systems: the bicarbonate buffer (H2CO3/HCO3−, pKa ≈ 6.1), the phosphate buffer (H2PO4−/HPO4 2−, pKa ≈ 7.2), and plasma proteins (particularly hemoglobin). Although the bicarbonate buffer's pKa of 6.1 is almost a full pH unit below physiological pH (7.4), it is the most physiologically important because the lungs and kidneys can rapidly adjust CO2 and HCO3− concentrations, respectively, providing dynamic control. The respiratory system compensates for acid-base disturbances within minutes, while renal compensation takes hours to days. Question 20: According to the Henderson-Hasselbalch equation in the passage, if a buffer has [A−] = 10 × [HA], what is the pH relative to the pKa?

Reading Comprehension

Question · Medium

Question

PASSAGE (Questions 21–25): Glaucoma is a group of progressive optic neuropathies characterized by the degeneration of retinal ganglion cells (RGCs) and their axons, which form the optic nerve. The most common form, primary open-angle glaucoma (POAG), is strongly associated with elevated intraocular pressure (IOP). IOP is determined by the balance between the production of aqueous humor by the ciliary body and its drainage through the trabecular meshwork into Schlemm's canal. Elevated IOP (ocular hypertension) is the leading modifiable risk factor for POAG, although approximately 30–40% of glaucoma patients present with IOP in the normal range (so-called normal-tension glaucoma), indicating that additional mechanisms—including vascular insufficiency and neuroinflammation—contribute to RGC loss. Current pharmacological treatments aim to lower IOP by reducing aqueous humor production or increasing its outflow. Prostaglandin analogs (e.g., latanoprost) increase uveoscleral outflow and are first-line agents due to their once-daily dosing and efficacy. Beta-blockers (e.g., timolol) reduce aqueous production by blocking beta-2 adrenergic receptors on the ciliary epithelium. Carbonic anhydrase inhibitors (e.g., dorzolamide) also reduce production by inhibiting bicarbonate formation necessary for aqueous secretion. Alpha-2 agonists (e.g., brimonidine) both decrease production and increase uveoscleral outflow. Laser trabeculoplasty and surgical trabeculectomy are options when pharmacological control is insufficient. Despite IOP-lowering therapy, glaucoma often continues to progress in some patients, suggesting that neuroprotection—directly shielding RGCs from apoptosis—is an important unmet need. Research has focused on BDNF (brain-derived neurotrophic factor) supplementation, NMDA receptor antagonists to reduce excitotoxicity, and antioxidant strategies. However, no neuroprotective agent has yet received regulatory approval for glaucoma specifically. The challenge is that RGC death in glaucoma is multifactorial, involving mitochondrial dysfunction, axonal transport failure, and immune-mediated injury, making a single-target approach difficult. Question 21: According to the passage, what percentage of glaucoma patients have IOP in the normal range?

Reading Comprehension

Question · Easy

Question

PASSAGE (Questions 21–25 — same passage as Q21): Glaucoma is a group of progressive optic neuropathies characterized by the degeneration of retinal ganglion cells (RGCs) and their axons, which form the optic nerve. The most common form, primary open-angle glaucoma (POAG), is strongly associated with elevated intraocular pressure (IOP). IOP is determined by the balance between the production of aqueous humor by the ciliary body and its drainage through the trabecular meshwork into Schlemm's canal. Elevated IOP (ocular hypertension) is the leading modifiable risk factor for POAG, although approximately 30–40% of glaucoma patients present with IOP in the normal range (so-called normal-tension glaucoma), indicating that additional mechanisms—including vascular insufficiency and neuroinflammation—contribute to RGC loss. Current pharmacological treatments aim to lower IOP by reducing aqueous humor production or increasing its outflow. Prostaglandin analogs (e.g., latanoprost) increase uveoscleral outflow and are first-line agents due to their once-daily dosing and efficacy. Beta-blockers (e.g., timolol) reduce aqueous production by blocking beta-2 adrenergic receptors on the ciliary epithelium. Carbonic anhydrase inhibitors (e.g., dorzolamide) also reduce production by inhibiting bicarbonate formation necessary for aqueous secretion. Alpha-2 agonists (e.g., brimonidine) both decrease production and increase uveoscleral outflow. Laser trabeculoplasty and surgical trabeculectomy are options when pharmacological control is insufficient. Despite IOP-lowering therapy, glaucoma often continues to progress in some patients, suggesting that neuroprotection—directly shielding RGCs from apoptosis—is an important unmet need. Research has focused on BDNF (brain-derived neurotrophic factor) supplementation, NMDA receptor antagonists to reduce excitotoxicity, and antioxidant strategies. However, no neuroprotective agent has yet received regulatory approval for glaucoma specifically. The challenge is that RGC death in glaucoma is multifactorial, involving mitochondrial dysfunction, axonal transport failure, and immune-mediated injury, making a single-target approach difficult. Question 22: Which drug class described in the passage works through BOTH reducing aqueous humor production AND increasing uveoscleral outflow?

Reading Comprehension

Question · Medium

Question

PASSAGE (Questions 21–25 — same passage as Q21): Glaucoma is a group of progressive optic neuropathies characterized by the degeneration of retinal ganglion cells (RGCs) and their axons, which form the optic nerve. The most common form, primary open-angle glaucoma (POAG), is strongly associated with elevated intraocular pressure (IOP). IOP is determined by the balance between the production of aqueous humor by the ciliary body and its drainage through the trabecular meshwork into Schlemm's canal. Elevated IOP (ocular hypertension) is the leading modifiable risk factor for POAG, although approximately 30–40% of glaucoma patients present with IOP in the normal range (so-called normal-tension glaucoma), indicating that additional mechanisms—including vascular insufficiency and neuroinflammation—contribute to RGC loss. Current pharmacological treatments aim to lower IOP by reducing aqueous humor production or increasing its outflow. Prostaglandin analogs (e.g., latanoprost) increase uveoscleral outflow and are first-line agents due to their once-daily dosing and efficacy. Beta-blockers (e.g., timolol) reduce aqueous production by blocking beta-2 adrenergic receptors on the ciliary epithelium. Carbonic anhydrase inhibitors (e.g., dorzolamide) also reduce production by inhibiting bicarbonate formation necessary for aqueous secretion. Alpha-2 agonists (e.g., brimonidine) both decrease production and increase uveoscleral outflow. Laser trabeculoplasty and surgical trabeculectomy are options when pharmacological control is insufficient. Despite IOP-lowering therapy, glaucoma often continues to progress in some patients, suggesting that neuroprotection—directly shielding RGCs from apoptosis—is an important unmet need. Research has focused on BDNF (brain-derived neurotrophic factor) supplementation, NMDA receptor antagonists to reduce excitotoxicity, and antioxidant strategies. However, no neuroprotective agent has yet received regulatory approval for glaucoma specifically. The challenge is that RGC death in glaucoma is multifactorial, involving mitochondrial dysfunction, axonal transport failure, and immune-mediated injury, making a single-target approach difficult. Question 23: The author's primary tone in the third paragraph can best be described as:

Reading Comprehension

Question · Medium

Question

PASSAGE (Questions 21–25 — same passage as Q21): Glaucoma is a group of progressive optic neuropathies characterized by the degeneration of retinal ganglion cells (RGCs) and their axons, which form the optic nerve. The most common form, primary open-angle glaucoma (POAG), is strongly associated with elevated intraocular pressure (IOP). IOP is determined by the balance between the production of aqueous humor by the ciliary body and its drainage through the trabecular meshwork into Schlemm's canal. Elevated IOP (ocular hypertension) is the leading modifiable risk factor for POAG, although approximately 30–40% of glaucoma patients present with IOP in the normal range (so-called normal-tension glaucoma), indicating that additional mechanisms—including vascular insufficiency and neuroinflammation—contribute to RGC loss. Current pharmacological treatments aim to lower IOP by reducing aqueous humor production or increasing its outflow. Prostaglandin analogs (e.g., latanoprost) increase uveoscleral outflow and are first-line agents due to their once-daily dosing and efficacy. Beta-blockers (e.g., timolol) reduce aqueous production by blocking beta-2 adrenergic receptors on the ciliary epithelium. Carbonic anhydrase inhibitors (e.g., dorzolamide) also reduce production by inhibiting bicarbonate formation necessary for aqueous secretion. Alpha-2 agonists (e.g., brimonidine) both decrease production and increase uveoscleral outflow. Laser trabeculoplasty and surgical trabeculectomy are options when pharmacological control is insufficient. Despite IOP-lowering therapy, glaucoma often continues to progress in some patients, suggesting that neuroprotection—directly shielding RGCs from apoptosis—is an important unmet need. Research has focused on BDNF (brain-derived neurotrophic factor) supplementation, NMDA receptor antagonists to reduce excitotoxicity, and antioxidant strategies. However, no neuroprotective agent has yet received regulatory approval for glaucoma specifically. The challenge is that RGC death in glaucoma is multifactorial, involving mitochondrial dysfunction, axonal transport failure, and immune-mediated injury, making a single-target approach difficult. Question 24: Based on the passage, which of the following can be inferred about trabeculectomy?

Reading Comprehension

Question · Medium

Question

PASSAGE (Questions 21–25 — same passage as Q21): Glaucoma is a group of progressive optic neuropathies characterized by the degeneration of retinal ganglion cells (RGCs) and their axons, which form the optic nerve. The most common form, primary open-angle glaucoma (POAG), is strongly associated with elevated intraocular pressure (IOP). IOP is determined by the balance between the production of aqueous humor by the ciliary body and its drainage through the trabecular meshwork into Schlemm's canal. Elevated IOP (ocular hypertension) is the leading modifiable risk factor for POAG, although approximately 30–40% of glaucoma patients present with IOP in the normal range (so-called normal-tension glaucoma), indicating that additional mechanisms—including vascular insufficiency and neuroinflammation—contribute to RGC loss. Current pharmacological treatments aim to lower IOP by reducing aqueous humor production or increasing its outflow. Prostaglandin analogs (e.g., latanoprost) increase uveoscleral outflow and are first-line agents due to their once-daily dosing and efficacy. Beta-blockers (e.g., timolol) reduce aqueous production by blocking beta-2 adrenergic receptors on the ciliary epithelium. Carbonic anhydrase inhibitors (e.g., dorzolamide) also reduce production by inhibiting bicarbonate formation necessary for aqueous secretion. Alpha-2 agonists (e.g., brimonidine) both decrease production and increase uveoscleral outflow. Laser trabeculoplasty and surgical trabeculectomy are options when pharmacological control is insufficient. Despite IOP-lowering therapy, glaucoma often continues to progress in some patients, suggesting that neuroprotection—directly shielding RGCs from apoptosis—is an important unmet need. Research has focused on BDNF (brain-derived neurotrophic factor) supplementation, NMDA receptor antagonists to reduce excitotoxicity, and antioxidant strategies. However, no neuroprotective agent has yet received regulatory approval for glaucoma specifically. The challenge is that RGC death in glaucoma is multifactorial, involving mitochondrial dysfunction, axonal transport failure, and immune-mediated injury, making a single-target approach difficult. Question 25: The phrase 'unmet need' as used in the passage most nearly means:

Reading Comprehension

Question · Medium

Question

PASSAGE (Questions 26–32): The human immune system is divided into two broad arms: innate immunity and adaptive immunity. Innate immunity provides the first, rapid line of defense. It is nonspecific—it responds the same way to any perceived threat—and does not improve with repeated exposure. Key components include physical barriers (skin, mucous membranes), phagocytic cells (neutrophils, macrophages, dendritic cells), natural killer (NK) cells, and the complement system. Pathogen recognition is mediated by pattern recognition receptors (PRRs), notably Toll-like receptors (TLRs), which detect conserved microbial features called pathogen-associated molecular patterns (PAMPs). Upon TLR activation, cells produce pro-inflammatory cytokines (e.g., IL-1beta, TNF-alpha, IL-6) that recruit additional immune cells and induce fever. Adaptive immunity is slower to mount (days to weeks) but is highly specific and develops immunological memory. It is mediated by lymphocytes: B cells and T cells. B cells, when activated, differentiate into plasma cells that secrete antibodies. Antibodies bind antigens with high specificity via their variable regions, facilitating neutralization, opsonization, and complement activation. T cells are subdivided into helper T cells (CD4+) and cytotoxic T cells (CD8+). CD4+ T cells secrete cytokines that coordinate both humoral (antibody-mediated) and cell-mediated immune responses, while CD8+ T cells directly kill infected or transformed cells expressing foreign peptides on MHC class I molecules. Immunological memory—the basis of vaccination—arises from the production of long-lived memory B and T cells after initial antigen exposure. Upon re-exposure to the same antigen, memory cells mount a faster, stronger, and more prolonged secondary immune response compared to the primary response. Vaccines exploit this principle by exposing the immune system to an antigen (or its mimic) without causing disease, generating protective memory. The concept of herd immunity relies on a sufficient proportion of a population being immune—either through vaccination or prior infection—to interrupt pathogen transmission and protect susceptible individuals. Question 26: According to the passage, what distinguishes innate immunity from adaptive immunity?

Reading Comprehension

Question · Easy

Question

PASSAGE (Questions 26–32 — same passage as Q26): The human immune system is divided into two broad arms: innate immunity and adaptive immunity. Innate immunity provides the first, rapid line of defense. It is nonspecific—it responds the same way to any perceived threat—and does not improve with repeated exposure. Key components include physical barriers (skin, mucous membranes), phagocytic cells (neutrophils, macrophages, dendritic cells), natural killer (NK) cells, and the complement system. Pathogen recognition is mediated by pattern recognition receptors (PRRs), notably Toll-like receptors (TLRs), which detect conserved microbial features called pathogen-associated molecular patterns (PAMPs). Upon TLR activation, cells produce pro-inflammatory cytokines (e.g., IL-1beta, TNF-alpha, IL-6) that recruit additional immune cells and induce fever. Adaptive immunity is slower to mount (days to weeks) but is highly specific and develops immunological memory. It is mediated by lymphocytes: B cells and T cells. B cells, when activated, differentiate into plasma cells that secrete antibodies. Antibodies bind antigens with high specificity via their variable regions, facilitating neutralization, opsonization, and complement activation. T cells are subdivided into helper T cells (CD4+) and cytotoxic T cells (CD8+). CD4+ T cells secrete cytokines that coordinate both humoral (antibody-mediated) and cell-mediated immune responses, while CD8+ T cells directly kill infected or transformed cells expressing foreign peptides on MHC class I molecules. Immunological memory—the basis of vaccination—arises from the production of long-lived memory B and T cells after initial antigen exposure. Upon re-exposure to the same antigen, memory cells mount a faster, stronger, and more prolonged secondary immune response compared to the primary response. Vaccines exploit this principle by exposing the immune system to an antigen (or its mimic) without causing disease, generating protective memory. The concept of herd immunity relies on a sufficient proportion of a population being immune—either through vaccination or prior infection—to interrupt pathogen transmission and protect susceptible individuals. Question 27: According to the passage, which cells directly kill infected cells displaying foreign peptides on MHC class I molecules?

Reading Comprehension

Question · Easy

Question

PASSAGE (Questions 26–32 — same passage as Q26): The human immune system is divided into two broad arms: innate immunity and adaptive immunity. Innate immunity provides the first, rapid line of defense. It is nonspecific—it responds the same way to any perceived threat—and does not improve with repeated exposure. Key components include physical barriers (skin, mucous membranes), phagocytic cells (neutrophils, macrophages, dendritic cells), natural killer (NK) cells, and the complement system. Pathogen recognition is mediated by pattern recognition receptors (PRRs), notably Toll-like receptors (TLRs), which detect conserved microbial features called pathogen-associated molecular patterns (PAMPs). Upon TLR activation, cells produce pro-inflammatory cytokines (e.g., IL-1beta, TNF-alpha, IL-6) that recruit additional immune cells and induce fever. Adaptive immunity is slower to mount (days to weeks) but is highly specific and develops immunological memory. It is mediated by lymphocytes: B cells and T cells. B cells, when activated, differentiate into plasma cells that secrete antibodies. Antibodies bind antigens with high specificity via their variable regions, facilitating neutralization, opsonization, and complement activation. T cells are subdivided into helper T cells (CD4+) and cytotoxic T cells (CD8+). CD4+ T cells secrete cytokines that coordinate both humoral (antibody-mediated) and cell-mediated immune responses, while CD8+ T cells directly kill infected or transformed cells expressing foreign peptides on MHC class I molecules. Immunological memory—the basis of vaccination—arises from the production of long-lived memory B and T cells after initial antigen exposure. Upon re-exposure to the same antigen, memory cells mount a faster, stronger, and more prolonged secondary immune response compared to the primary response. Vaccines exploit this principle by exposing the immune system to an antigen (or its mimic) without causing disease, generating protective memory. The concept of herd immunity relies on a sufficient proportion of a population being immune—either through vaccination or prior infection—to interrupt pathogen transmission and protect susceptible individuals. Question 28: An individual who has never encountered a particular pathogen would have which type of initial immune response, and how long would adaptive immunity take to activate?

Reading Comprehension

Question · Easy

Question

PASSAGE (Questions 26–32 — same passage as Q26): The human immune system is divided into two broad arms: innate immunity and adaptive immunity. Innate immunity provides the first, rapid line of defense. It is nonspecific—it responds the same way to any perceived threat—and does not improve with repeated exposure. Key components include physical barriers (skin, mucous membranes), phagocytic cells (neutrophils, macrophages, dendritic cells), natural killer (NK) cells, and the complement system. Pathogen recognition is mediated by pattern recognition receptors (PRRs), notably Toll-like receptors (TLRs), which detect conserved microbial features called pathogen-associated molecular patterns (PAMPs). Upon TLR activation, cells produce pro-inflammatory cytokines (e.g., IL-1beta, TNF-alpha, IL-6) that recruit additional immune cells and induce fever. Adaptive immunity is slower to mount (days to weeks) but is highly specific and develops immunological memory. It is mediated by lymphocytes: B cells and T cells. B cells, when activated, differentiate into plasma cells that secrete antibodies. Antibodies bind antigens with high specificity via their variable regions, facilitating neutralization, opsonization, and complement activation. T cells are subdivided into helper T cells (CD4+) and cytotoxic T cells (CD8+). CD4+ T cells secrete cytokines that coordinate both humoral (antibody-mediated) and cell-mediated immune responses, while CD8+ T cells directly kill infected or transformed cells expressing foreign peptides on MHC class I molecules. Immunological memory—the basis of vaccination—arises from the production of long-lived memory B and T cells after initial antigen exposure. Upon re-exposure to the same antigen, memory cells mount a faster, stronger, and more prolonged secondary immune response compared to the primary response. Vaccines exploit this principle by exposing the immune system to an antigen (or its mimic) without causing disease, generating protective memory. The concept of herd immunity relies on a sufficient proportion of a population being immune—either through vaccination or prior infection—to interrupt pathogen transmission and protect susceptible individuals. Question 29: The passage implies that vaccines are effective primarily because they:

Reading Comprehension

Question · Easy

Question

PASSAGE (Questions 26–32 — same passage as Q26): The human immune system is divided into two broad arms: innate immunity and adaptive immunity. Innate immunity provides the first, rapid line of defense. It is nonspecific—it responds the same way to any perceived threat—and does not improve with repeated exposure. Key components include physical barriers (skin, mucous membranes), phagocytic cells (neutrophils, macrophages, dendritic cells), natural killer (NK) cells, and the complement system. Pathogen recognition is mediated by pattern recognition receptors (PRRs), notably Toll-like receptors (TLRs), which detect conserved microbial features called pathogen-associated molecular patterns (PAMPs). Upon TLR activation, cells produce pro-inflammatory cytokines (e.g., IL-1beta, TNF-alpha, IL-6) that recruit additional immune cells and induce fever. Adaptive immunity is slower to mount (days to weeks) but is highly specific and develops immunological memory. It is mediated by lymphocytes: B cells and T cells. B cells, when activated, differentiate into plasma cells that secrete antibodies. Antibodies bind antigens with high specificity via their variable regions, facilitating neutralization, opsonization, and complement activation. T cells are subdivided into helper T cells (CD4+) and cytotoxic T cells (CD8+). CD4+ T cells secrete cytokines that coordinate both humoral (antibody-mediated) and cell-mediated immune responses, while CD8+ T cells directly kill infected or transformed cells expressing foreign peptides on MHC class I molecules. Immunological memory—the basis of vaccination—arises from the production of long-lived memory B and T cells after initial antigen exposure. Upon re-exposure to the same antigen, memory cells mount a faster, stronger, and more prolonged secondary immune response compared to the primary response. Vaccines exploit this principle by exposing the immune system to an antigen (or its mimic) without causing disease, generating protective memory. The concept of herd immunity relies on a sufficient proportion of a population being immune—either through vaccination or prior infection—to interrupt pathogen transmission and protect susceptible individuals. Question 30: As used in the passage, 'opsonization' most likely refers to:

Reading Comprehension

Question · Medium

Question

PASSAGE (Questions 26–32 — same passage as Q26): The human immune system is divided into two broad arms: innate immunity and adaptive immunity. Innate immunity provides the first, rapid line of defense. It is nonspecific—it responds the same way to any perceived threat—and does not improve with repeated exposure. Key components include physical barriers (skin, mucous membranes), phagocytic cells (neutrophils, macrophages, dendritic cells), natural killer (NK) cells, and the complement system. Pathogen recognition is mediated by pattern recognition receptors (PRRs), notably Toll-like receptors (TLRs), which detect conserved microbial features called pathogen-associated molecular patterns (PAMPs). Upon TLR activation, cells produce pro-inflammatory cytokines (e.g., IL-1beta, TNF-alpha, IL-6) that recruit additional immune cells and induce fever. Adaptive immunity is slower to mount (days to weeks) but is highly specific and develops immunological memory. It is mediated by lymphocytes: B cells and T cells. B cells, when activated, differentiate into plasma cells that secrete antibodies. Antibodies bind antigens with high specificity via their variable regions, facilitating neutralization, opsonization, and complement activation. T cells are subdivided into helper T cells (CD4+) and cytotoxic T cells (CD8+). CD4+ T cells secrete cytokines that coordinate both humoral (antibody-mediated) and cell-mediated immune responses, while CD8+ T cells directly kill infected or transformed cells expressing foreign peptides on MHC class I molecules. Immunological memory—the basis of vaccination—arises from the production of long-lived memory B and T cells after initial antigen exposure. Upon re-exposure to the same antigen, memory cells mount a faster, stronger, and more prolonged secondary immune response compared to the primary response. Vaccines exploit this principle by exposing the immune system to an antigen (or its mimic) without causing disease, generating protective memory. The concept of herd immunity relies on a sufficient proportion of a population being immune—either through vaccination or prior infection—to interrupt pathogen transmission and protect susceptible individuals. Question 31: Which best describes the overall organizational structure of this passage?

Reading Comprehension

Question · Medium

Question

PASSAGE (Questions 26–32 — same passage as Q26): The human immune system is divided into two broad arms: innate immunity and adaptive immunity. Innate immunity provides the first, rapid line of defense. It is nonspecific—it responds the same way to any perceived threat—and does not improve with repeated exposure. Key components include physical barriers (skin, mucous membranes), phagocytic cells (neutrophils, macrophages, dendritic cells), natural killer (NK) cells, and the complement system. Pathogen recognition is mediated by pattern recognition receptors (PRRs), notably Toll-like receptors (TLRs), which detect conserved microbial features called pathogen-associated molecular patterns (PAMPs). Upon TLR activation, cells produce pro-inflammatory cytokines (e.g., IL-1beta, TNF-alpha, IL-6) that recruit additional immune cells and induce fever. Adaptive immunity is slower to mount (days to weeks) but is highly specific and develops immunological memory. It is mediated by lymphocytes: B cells and T cells. B cells, when activated, differentiate into plasma cells that secrete antibodies. Antibodies bind antigens with high specificity via their variable regions, facilitating neutralization, opsonization, and complement activation. T cells are subdivided into helper T cells (CD4+) and cytotoxic T cells (CD8+). CD4+ T cells secrete cytokines that coordinate both humoral (antibody-mediated) and cell-mediated immune responses, while CD8+ T cells directly kill infected or transformed cells expressing foreign peptides on MHC class I molecules. Immunological memory—the basis of vaccination—arises from the production of long-lived memory B and T cells after initial antigen exposure. Upon re-exposure to the same antigen, memory cells mount a faster, stronger, and more prolonged secondary immune response compared to the primary response. Vaccines exploit this principle by exposing the immune system to an antigen (or its mimic) without causing disease, generating protective memory. The concept of herd immunity relies on a sufficient proportion of a population being immune—either through vaccination or prior infection—to interrupt pathogen transmission and protect susceptible individuals. Question 32: According to the passage, what is the purpose of herd immunity?

Reading Comprehension

Question · Easy

Question

PASSAGE (Questions 33–39): DNA replication is a highly coordinated process that ensures accurate copying of the genome prior to cell division. Replication begins at specific chromosomal sequences called origins of replication. In prokaryotes such as Escherichia coli, there is a single origin (oriC), whereas eukaryotic chromosomes have multiple origins that fire simultaneously to complete replication in a reasonable time frame. At each origin, the double helix is unwound by helicase, creating a replication fork that moves bidirectionally. Single-strand binding proteins (SSBPs) stabilize the unwound strands, and topoisomerase relieves the supercoiling tension ahead of the fork. DNA polymerase—the central enzyme of replication—adds nucleotides only in the 5' to 3' direction. Because the two template strands are antiparallel, one strand (the leading strand) is synthesized continuously in the direction the fork moves. The other strand (the lagging strand) must be synthesized in short, discontinuous fragments called Okazaki fragments, each primed by a short RNA primer synthesized by primase. After each Okazaki fragment is extended, the RNA primer is removed by DNA polymerase I (in prokaryotes) or RNase H/FEN1 (in eukaryotes), and the resulting gap is filled with DNA. DNA ligase then seals the nicks between adjacent fragments, creating a continuous lagging strand. Fidelity of replication is maintained by the 3'to 5' exonuclease proofreading activity of DNA polymerase, which excises mismatched nucleotides immediately after incorporation. Additionally, the mismatch repair (MMR) system corrects errors that escape proofreading. Combined, these mechanisms reduce the replication error rate to approximately 1 in 10 billion to 100 billion nucleotides. In cancer biology, mutations in MMR genes (e.g., MLH1, MSH2) lead to a condition called microsatellite instability, characterized by widespread small insertions and deletions throughout the genome and a dramatically elevated mutation rate. Question 33: According to the passage, why does the lagging strand require Okazaki fragments?

Reading Comprehension

Question · Medium

Question

PASSAGE (Questions 33–39 — same passage as Q33): DNA replication is a highly coordinated process that ensures accurate copying of the genome prior to cell division. Replication begins at specific chromosomal sequences called origins of replication. In prokaryotes such as Escherichia coli, there is a single origin (oriC), whereas eukaryotic chromosomes have multiple origins that fire simultaneously to complete replication in a reasonable time frame. At each origin, the double helix is unwound by helicase, creating a replication fork that moves bidirectionally. Single-strand binding proteins (SSBPs) stabilize the unwound strands, and topoisomerase relieves the supercoiling tension ahead of the fork. DNA polymerase—the central enzyme of replication—adds nucleotides only in the 5' to 3' direction. Because the two template strands are antiparallel, one strand (the leading strand) is synthesized continuously in the direction the fork moves. The other strand (the lagging strand) must be synthesized in short, discontinuous fragments called Okazaki fragments, each primed by a short RNA primer synthesized by primase. After each Okazaki fragment is extended, the RNA primer is removed by DNA polymerase I (in prokaryotes) or RNase H/FEN1 (in eukaryotes), and the resulting gap is filled with DNA. DNA ligase then seals the nicks between adjacent fragments, creating a continuous lagging strand. Fidelity of replication is maintained by the 3'to 5' exonuclease proofreading activity of DNA polymerase, which excises mismatched nucleotides immediately after incorporation. Additionally, the mismatch repair (MMR) system corrects errors that escape proofreading. Combined, these mechanisms reduce the replication error rate to approximately 1 in 10 billion to 100 billion nucleotides. In cancer biology, mutations in MMR genes (e.g., MLH1, MSH2) lead to a condition called microsatellite instability, characterized by widespread small insertions and deletions throughout the genome and a dramatically elevated mutation rate. Question 34: In prokaryotes, which enzyme removes the RNA primers after Okazaki fragment synthesis?

Reading Comprehension

Question · Easy

Question

PASSAGE (Questions 33–39 — same passage as Q33): DNA replication is a highly coordinated process that ensures accurate copying of the genome prior to cell division. Replication begins at specific chromosomal sequences called origins of replication. In prokaryotes such as Escherichia coli, there is a single origin (oriC), whereas eukaryotic chromosomes have multiple origins that fire simultaneously to complete replication in a reasonable time frame. At each origin, the double helix is unwound by helicase, creating a replication fork that moves bidirectionally. Single-strand binding proteins (SSBPs) stabilize the unwound strands, and topoisomerase relieves the supercoiling tension ahead of the fork. DNA polymerase—the central enzyme of replication—adds nucleotides only in the 5' to 3' direction. Because the two template strands are antiparallel, one strand (the leading strand) is synthesized continuously in the direction the fork moves. The other strand (the lagging strand) must be synthesized in short, discontinuous fragments called Okazaki fragments, each primed by a short RNA primer synthesized by primase. After each Okazaki fragment is extended, the RNA primer is removed by DNA polymerase I (in prokaryotes) or RNase H/FEN1 (in eukaryotes), and the resulting gap is filled with DNA. DNA ligase then seals the nicks between adjacent fragments, creating a continuous lagging strand. Fidelity of replication is maintained by the 3'to 5' exonuclease proofreading activity of DNA polymerase, which excises mismatched nucleotides immediately after incorporation. Additionally, the mismatch repair (MMR) system corrects errors that escape proofreading. Combined, these mechanisms reduce the replication error rate to approximately 1 in 10 billion to 100 billion nucleotides. In cancer biology, mutations in MMR genes (e.g., MLH1, MSH2) lead to a condition called microsatellite instability, characterized by widespread small insertions and deletions throughout the genome and a dramatically elevated mutation rate. Question 35: The passage implies eukaryotic chromosomes have multiple replication origins rather than one primarily because:

Reading Comprehension

Question · Medium

Question

PASSAGE (Questions 33–39 — same passage as Q33): DNA replication is a highly coordinated process that ensures accurate copying of the genome prior to cell division. Replication begins at specific chromosomal sequences called origins of replication. In prokaryotes such as Escherichia coli, there is a single origin (oriC), whereas eukaryotic chromosomes have multiple origins that fire simultaneously to complete replication in a reasonable time frame. At each origin, the double helix is unwound by helicase, creating a replication fork that moves bidirectionally. Single-strand binding proteins (SSBPs) stabilize the unwound strands, and topoisomerase relieves the supercoiling tension ahead of the fork. DNA polymerase—the central enzyme of replication—adds nucleotides only in the 5' to 3' direction. Because the two template strands are antiparallel, one strand (the leading strand) is synthesized continuously in the direction the fork moves. The other strand (the lagging strand) must be synthesized in short, discontinuous fragments called Okazaki fragments, each primed by a short RNA primer synthesized by primase. After each Okazaki fragment is extended, the RNA primer is removed by DNA polymerase I (in prokaryotes) or RNase H/FEN1 (in eukaryotes), and the resulting gap is filled with DNA. DNA ligase then seals the nicks between adjacent fragments, creating a continuous lagging strand. Fidelity of replication is maintained by the 3'to 5' exonuclease proofreading activity of DNA polymerase, which excises mismatched nucleotides immediately after incorporation. Additionally, the mismatch repair (MMR) system corrects errors that escape proofreading. Combined, these mechanisms reduce the replication error rate to approximately 1 in 10 billion to 100 billion nucleotides. In cancer biology, mutations in MMR genes (e.g., MLH1, MSH2) lead to a condition called microsatellite instability, characterized by widespread small insertions and deletions throughout the genome and a dramatically elevated mutation rate. Question 36: What would MOST LIKELY occur if the mismatch repair (MMR) system were completely inactivated in a cell?

Reading Comprehension

Question · Medium

Question

PASSAGE (Questions 33–39 — same passage as Q33): DNA replication is a highly coordinated process that ensures accurate copying of the genome prior to cell division. Replication begins at specific chromosomal sequences called origins of replication. In prokaryotes such as Escherichia coli, there is a single origin (oriC), whereas eukaryotic chromosomes have multiple origins that fire simultaneously to complete replication in a reasonable time frame. At each origin, the double helix is unwound by helicase, creating a replication fork that moves bidirectionally. Single-strand binding proteins (SSBPs) stabilize the unwound strands, and topoisomerase relieves the supercoiling tension ahead of the fork. DNA polymerase—the central enzyme of replication—adds nucleotides only in the 5' to 3' direction. Because the two template strands are antiparallel, one strand (the leading strand) is synthesized continuously in the direction the fork moves. The other strand (the lagging strand) must be synthesized in short, discontinuous fragments called Okazaki fragments, each primed by a short RNA primer synthesized by primase. After each Okazaki fragment is extended, the RNA primer is removed by DNA polymerase I (in prokaryotes) or RNase H/FEN1 (in eukaryotes), and the resulting gap is filled with DNA. DNA ligase then seals the nicks between adjacent fragments, creating a continuous lagging strand. Fidelity of replication is maintained by the 3'to 5' exonuclease proofreading activity of DNA polymerase, which excises mismatched nucleotides immediately after incorporation. Additionally, the mismatch repair (MMR) system corrects errors that escape proofreading. Combined, these mechanisms reduce the replication error rate to approximately 1 in 10 billion to 100 billion nucleotides. In cancer biology, mutations in MMR genes (e.g., MLH1, MSH2) lead to a condition called microsatellite instability, characterized by widespread small insertions and deletions throughout the genome and a dramatically elevated mutation rate. Question 37: According to the passage, the replication fork moves in which direction from the origin?

Reading Comprehension

Question · Easy

Question

PASSAGE (Questions 33–39 — same passage as Q33): DNA replication is a highly coordinated process that ensures accurate copying of the genome prior to cell division. Replication begins at specific chromosomal sequences called origins of replication. In prokaryotes such as Escherichia coli, there is a single origin (oriC), whereas eukaryotic chromosomes have multiple origins that fire simultaneously to complete replication in a reasonable time frame. At each origin, the double helix is unwound by helicase, creating a replication fork that moves bidirectionally. Single-strand binding proteins (SSBPs) stabilize the unwound strands, and topoisomerase relieves the supercoiling tension ahead of the fork. DNA polymerase—the central enzyme of replication—adds nucleotides only in the 5' to 3' direction. Because the two template strands are antiparallel, one strand (the leading strand) is synthesized continuously in the direction the fork moves. The other strand (the lagging strand) must be synthesized in short, discontinuous fragments called Okazaki fragments, each primed by a short RNA primer synthesized by primase. After each Okazaki fragment is extended, the RNA primer is removed by DNA polymerase I (in prokaryotes) or RNase H/FEN1 (in eukaryotes), and the resulting gap is filled with DNA. DNA ligase then seals the nicks between adjacent fragments, creating a continuous lagging strand. Fidelity of replication is maintained by the 3'to 5' exonuclease proofreading activity of DNA polymerase, which excises mismatched nucleotides immediately after incorporation. Additionally, the mismatch repair (MMR) system corrects errors that escape proofreading. Combined, these mechanisms reduce the replication error rate to approximately 1 in 10 billion to 100 billion nucleotides. In cancer biology, mutations in MMR genes (e.g., MLH1, MSH2) lead to a condition called microsatellite instability, characterized by widespread small insertions and deletions throughout the genome and a dramatically elevated mutation rate. Question 38: As used in the passage, 'microsatellite instability' most nearly refers to:

Reading Comprehension

Question · Medium

Question

PASSAGE (Questions 33–39 — same passage as Q33): DNA replication is a highly coordinated process that ensures accurate copying of the genome prior to cell division. Replication begins at specific chromosomal sequences called origins of replication. In prokaryotes such as Escherichia coli, there is a single origin (oriC), whereas eukaryotic chromosomes have multiple origins that fire simultaneously to complete replication in a reasonable time frame. At each origin, the double helix is unwound by helicase, creating a replication fork that moves bidirectionally. Single-strand binding proteins (SSBPs) stabilize the unwound strands, and topoisomerase relieves the supercoiling tension ahead of the fork. DNA polymerase—the central enzyme of replication—adds nucleotides only in the 5' to 3' direction. Because the two template strands are antiparallel, one strand (the leading strand) is synthesized continuously in the direction the fork moves. The other strand (the lagging strand) must be synthesized in short, discontinuous fragments called Okazaki fragments, each primed by a short RNA primer synthesized by primase. After each Okazaki fragment is extended, the RNA primer is removed by DNA polymerase I (in prokaryotes) or RNase H/FEN1 (in eukaryotes), and the resulting gap is filled with DNA. DNA ligase then seals the nicks between adjacent fragments, creating a continuous lagging strand. Fidelity of replication is maintained by the 3'to 5' exonuclease proofreading activity of DNA polymerase, which excises mismatched nucleotides immediately after incorporation. Additionally, the mismatch repair (MMR) system corrects errors that escape proofreading. Combined, these mechanisms reduce the replication error rate to approximately 1 in 10 billion to 100 billion nucleotides. In cancer biology, mutations in MMR genes (e.g., MLH1, MSH2) lead to a condition called microsatellite instability, characterized by widespread small insertions and deletions throughout the genome and a dramatically elevated mutation rate. Question 39: The passage's discussion of DNA replication fidelity is BEST described as:

Reading Comprehension

Question · Hard

Question

PASSAGE (Questions 40–46): The cardiovascular system is a closed circulatory system consisting of the heart, blood vessels, and blood. The heart is divided into four chambers: two atria (receiving chambers) and two ventricles (pumping chambers). Deoxygenated blood from the systemic circulation returns to the right atrium via the superior and inferior venae cavae, then flows through the tricuspid valve into the right ventricle, which pumps it through the pulmonary valve into the pulmonary arteries toward the lungs. In the lungs, gas exchange occurs across thin alveolar-capillary membranes: CO2 diffuses from blood into alveoli and O2 moves from alveoli into blood. Oxygenated blood returns to the left atrium through the pulmonary veins, passes through the mitral valve into the left ventricle, and is ejected through the aortic valve into the aorta for systemic distribution. Cardiac output (CO) is the volume of blood ejected by one ventricle per minute and is calculated as CO = stroke volume (SV) x heart rate (HR). Stroke volume is influenced by preload (ventricular filling), afterload (arterial resistance opposing ejection), and contractility (intrinsic myocardial force). The Frank-Starling law states that increased ventricular filling (preload) stretches the myocardium, increasing stroke volume up to a physiological limit. Heart rate is regulated by the sinoatrial (SA) node, the primary pacemaker; sympathetic stimulation increases HR via norepinephrine acting on beta-1 receptors, while parasympathetic stimulation (vagal tone) decreases HR via acetylcholine acting on muscarinic receptors. Blood pressure (BP) is determined by CO and total peripheral resistance (TPR): BP = CO x TPR. Arteries carry blood away from the heart under high pressure; veins return blood under low pressure; capillaries are the sites of material exchange with tissues. Hypertension (BP > 130/80 mmHg chronically) damages vessel walls, promotes atherosclerosis, and increases the risk of heart attack and stroke. Antihypertensive strategies include reducing CO (e.g., beta-blockers lowering HR) and reducing TPR (e.g., vasodilators and ACE inhibitors). Question 40: Based on the passage, which sequence correctly traces blood flow from the body's tissues back to the lungs?

Reading Comprehension

Question · Easy

Question

PASSAGE (Questions 40–46 — same passage as Q40): The cardiovascular system is a closed circulatory system consisting of the heart, blood vessels, and blood. The heart is divided into four chambers: two atria (receiving chambers) and two ventricles (pumping chambers). Deoxygenated blood from the systemic circulation returns to the right atrium via the superior and inferior venae cavae, then flows through the tricuspid valve into the right ventricle, which pumps it through the pulmonary valve into the pulmonary arteries toward the lungs. In the lungs, gas exchange occurs across thin alveolar-capillary membranes: CO2 diffuses from blood into alveoli and O2 moves from alveoli into blood. Oxygenated blood returns to the left atrium through the pulmonary veins, passes through the mitral valve into the left ventricle, and is ejected through the aortic valve into the aorta for systemic distribution. Cardiac output (CO) is the volume of blood ejected by one ventricle per minute and is calculated as CO = stroke volume (SV) x heart rate (HR). Stroke volume is influenced by preload (ventricular filling), afterload (arterial resistance opposing ejection), and contractility (intrinsic myocardial force). The Frank-Starling law states that increased ventricular filling (preload) stretches the myocardium, increasing stroke volume up to a physiological limit. Heart rate is regulated by the sinoatrial (SA) node, the primary pacemaker; sympathetic stimulation increases HR via norepinephrine acting on beta-1 receptors, while parasympathetic stimulation (vagal tone) decreases HR via acetylcholine acting on muscarinic receptors. Blood pressure (BP) is determined by CO and total peripheral resistance (TPR): BP = CO x TPR. Arteries carry blood away from the heart under high pressure; veins return blood under low pressure; capillaries are the sites of material exchange with tissues. Hypertension (BP > 130/80 mmHg chronically) damages vessel walls, promotes atherosclerosis, and increases the risk of heart attack and stroke. Antihypertensive strategies include reducing CO (e.g., beta-blockers lowering HR) and reducing TPR (e.g., vasodilators and ACE inhibitors). Question 41: According to the Frank-Starling law, what would happen to stroke volume if ventricular filling increased?

Reading Comprehension

Question · Easy

Question

PASSAGE (Questions 40–46 — same passage as Q40): The cardiovascular system is a closed circulatory system consisting of the heart, blood vessels, and blood. The heart is divided into four chambers: two atria (receiving chambers) and two ventricles (pumping chambers). Deoxygenated blood from the systemic circulation returns to the right atrium via the superior and inferior venae cavae, then flows through the tricuspid valve into the right ventricle, which pumps it through the pulmonary valve into the pulmonary arteries toward the lungs. In the lungs, gas exchange occurs across thin alveolar-capillary membranes: CO2 diffuses from blood into alveoli and O2 moves from alveoli into blood. Oxygenated blood returns to the left atrium through the pulmonary veins, passes through the mitral valve into the left ventricle, and is ejected through the aortic valve into the aorta for systemic distribution. Cardiac output (CO) is the volume of blood ejected by one ventricle per minute and is calculated as CO = stroke volume (SV) x heart rate (HR). Stroke volume is influenced by preload (ventricular filling), afterload (arterial resistance opposing ejection), and contractility (intrinsic myocardial force). The Frank-Starling law states that increased ventricular filling (preload) stretches the myocardium, increasing stroke volume up to a physiological limit. Heart rate is regulated by the sinoatrial (SA) node, the primary pacemaker; sympathetic stimulation increases HR via norepinephrine acting on beta-1 receptors, while parasympathetic stimulation (vagal tone) decreases HR via acetylcholine acting on muscarinic receptors. Blood pressure (BP) is determined by CO and total peripheral resistance (TPR): BP = CO x TPR. Arteries carry blood away from the heart under high pressure; veins return blood under low pressure; capillaries are the sites of material exchange with tissues. Hypertension (BP > 130/80 mmHg chronically) damages vessel walls, promotes atherosclerosis, and increases the risk of heart attack and stroke. Antihypertensive strategies include reducing CO (e.g., beta-blockers lowering HR) and reducing TPR (e.g., vasodilators and ACE inhibitors). Question 42: If a patient's heart rate is 75 beats/min and stroke volume is 70 mL/beat, what is the cardiac output according to the formula in the passage?

Reading Comprehension

Question · Medium

Question

PASSAGE (Questions 40–46 — same passage as Q40): The cardiovascular system is a closed circulatory system consisting of the heart, blood vessels, and blood. The heart is divided into four chambers: two atria (receiving chambers) and two ventricles (pumping chambers). Deoxygenated blood from the systemic circulation returns to the right atrium via the superior and inferior venae cavae, then flows through the tricuspid valve into the right ventricle, which pumps it through the pulmonary valve into the pulmonary arteries toward the lungs. In the lungs, gas exchange occurs across thin alveolar-capillary membranes: CO2 diffuses from blood into alveoli and O2 moves from alveoli into blood. Oxygenated blood returns to the left atrium through the pulmonary veins, passes through the mitral valve into the left ventricle, and is ejected through the aortic valve into the aorta for systemic distribution. Cardiac output (CO) is the volume of blood ejected by one ventricle per minute and is calculated as CO = stroke volume (SV) x heart rate (HR). Stroke volume is influenced by preload (ventricular filling), afterload (arterial resistance opposing ejection), and contractility (intrinsic myocardial force). The Frank-Starling law states that increased ventricular filling (preload) stretches the myocardium, increasing stroke volume up to a physiological limit. Heart rate is regulated by the sinoatrial (SA) node, the primary pacemaker; sympathetic stimulation increases HR via norepinephrine acting on beta-1 receptors, while parasympathetic stimulation (vagal tone) decreases HR via acetylcholine acting on muscarinic receptors. Blood pressure (BP) is determined by CO and total peripheral resistance (TPR): BP = CO x TPR. Arteries carry blood away from the heart under high pressure; veins return blood under low pressure; capillaries are the sites of material exchange with tissues. Hypertension (BP > 130/80 mmHg chronically) damages vessel walls, promotes atherosclerosis, and increases the risk of heart attack and stroke. Antihypertensive strategies include reducing CO (e.g., beta-blockers lowering HR) and reducing TPR (e.g., vasodilators and ACE inhibitors). Question 43: According to the passage, how does a beta-blocker lower blood pressure?

Reading Comprehension

Question · Medium

Question

PASSAGE (Questions 40–46 — same passage as Q40): The cardiovascular system is a closed circulatory system consisting of the heart, blood vessels, and blood. The heart is divided into four chambers: two atria (receiving chambers) and two ventricles (pumping chambers). Deoxygenated blood from the systemic circulation returns to the right atrium via the superior and inferior venae cavae, then flows through the tricuspid valve into the right ventricle, which pumps it through the pulmonary valve into the pulmonary arteries toward the lungs. In the lungs, gas exchange occurs across thin alveolar-capillary membranes: CO2 diffuses from blood into alveoli and O2 moves from alveoli into blood. Oxygenated blood returns to the left atrium through the pulmonary veins, passes through the mitral valve into the left ventricle, and is ejected through the aortic valve into the aorta for systemic distribution. Cardiac output (CO) is the volume of blood ejected by one ventricle per minute and is calculated as CO = stroke volume (SV) x heart rate (HR). Stroke volume is influenced by preload (ventricular filling), afterload (arterial resistance opposing ejection), and contractility (intrinsic myocardial force). The Frank-Starling law states that increased ventricular filling (preload) stretches the myocardium, increasing stroke volume up to a physiological limit. Heart rate is regulated by the sinoatrial (SA) node, the primary pacemaker; sympathetic stimulation increases HR via norepinephrine acting on beta-1 receptors, while parasympathetic stimulation (vagal tone) decreases HR via acetylcholine acting on muscarinic receptors. Blood pressure (BP) is determined by CO and total peripheral resistance (TPR): BP = CO x TPR. Arteries carry blood away from the heart under high pressure; veins return blood under low pressure; capillaries are the sites of material exchange with tissues. Hypertension (BP > 130/80 mmHg chronically) damages vessel walls, promotes atherosclerosis, and increases the risk of heart attack and stroke. Antihypertensive strategies include reducing CO (e.g., beta-blockers lowering HR) and reducing TPR (e.g., vasodilators and ACE inhibitors). Question 44: As used in the passage, the term 'afterload' most nearly means:

Reading Comprehension

Question · Easy

Question

PASSAGE (Questions 40–46 — same passage as Q40): The cardiovascular system is a closed circulatory system consisting of the heart, blood vessels, and blood. The heart is divided into four chambers: two atria (receiving chambers) and two ventricles (pumping chambers). Deoxygenated blood from the systemic circulation returns to the right atrium via the superior and inferior venae cavae, then flows through the tricuspid valve into the right ventricle, which pumps it through the pulmonary valve into the pulmonary arteries toward the lungs. In the lungs, gas exchange occurs across thin alveolar-capillary membranes: CO2 diffuses from blood into alveoli and O2 moves from alveoli into blood. Oxygenated blood returns to the left atrium through the pulmonary veins, passes through the mitral valve into the left ventricle, and is ejected through the aortic valve into the aorta for systemic distribution. Cardiac output (CO) is the volume of blood ejected by one ventricle per minute and is calculated as CO = stroke volume (SV) x heart rate (HR). Stroke volume is influenced by preload (ventricular filling), afterload (arterial resistance opposing ejection), and contractility (intrinsic myocardial force). The Frank-Starling law states that increased ventricular filling (preload) stretches the myocardium, increasing stroke volume up to a physiological limit. Heart rate is regulated by the sinoatrial (SA) node, the primary pacemaker; sympathetic stimulation increases HR via norepinephrine acting on beta-1 receptors, while parasympathetic stimulation (vagal tone) decreases HR via acetylcholine acting on muscarinic receptors. Blood pressure (BP) is determined by CO and total peripheral resistance (TPR): BP = CO x TPR. Arteries carry blood away from the heart under high pressure; veins return blood under low pressure; capillaries are the sites of material exchange with tissues. Hypertension (BP > 130/80 mmHg chronically) damages vessel walls, promotes atherosclerosis, and increases the risk of heart attack and stroke. Antihypertensive strategies include reducing CO (e.g., beta-blockers lowering HR) and reducing TPR (e.g., vasodilators and ACE inhibitors). Question 45: Based on the passage, during intense exercise sympathetic nervous system activation would be expected to:

Reading Comprehension

Question · Medium

Question

PASSAGE (Questions 40–46 — same passage as Q40): The cardiovascular system is a closed circulatory system consisting of the heart, blood vessels, and blood. The heart is divided into four chambers: two atria (receiving chambers) and two ventricles (pumping chambers). Deoxygenated blood from the systemic circulation returns to the right atrium via the superior and inferior venae cavae, then flows through the tricuspid valve into the right ventricle, which pumps it through the pulmonary valve into the pulmonary arteries toward the lungs. In the lungs, gas exchange occurs across thin alveolar-capillary membranes: CO2 diffuses from blood into alveoli and O2 moves from alveoli into blood. Oxygenated blood returns to the left atrium through the pulmonary veins, passes through the mitral valve into the left ventricle, and is ejected through the aortic valve into the aorta for systemic distribution. Cardiac output (CO) is the volume of blood ejected by one ventricle per minute and is calculated as CO = stroke volume (SV) x heart rate (HR). Stroke volume is influenced by preload (ventricular filling), afterload (arterial resistance opposing ejection), and contractility (intrinsic myocardial force). The Frank-Starling law states that increased ventricular filling (preload) stretches the myocardium, increasing stroke volume up to a physiological limit. Heart rate is regulated by the sinoatrial (SA) node, the primary pacemaker; sympathetic stimulation increases HR via norepinephrine acting on beta-1 receptors, while parasympathetic stimulation (vagal tone) decreases HR via acetylcholine acting on muscarinic receptors. Blood pressure (BP) is determined by CO and total peripheral resistance (TPR): BP = CO x TPR. Arteries carry blood away from the heart under high pressure; veins return blood under low pressure; capillaries are the sites of material exchange with tissues. Hypertension (BP > 130/80 mmHg chronically) damages vessel walls, promotes atherosclerosis, and increases the risk of heart attack and stroke. Antihypertensive strategies include reducing CO (e.g., beta-blockers lowering HR) and reducing TPR (e.g., vasodilators and ACE inhibitors). Question 46: The main idea of the third paragraph is BEST summarized as:

Reading Comprehension

Question · Medium

Question

PASSAGE (Questions 47–50): Cell signaling is the process by which cells communicate with one another and with their environment. Signaling molecules (ligands) bind to receptors and initiate intracellular cascades that alter cell behavior. Signaling can occur over varying distances: autocrine signaling targets the same cell that releases the signal; paracrine signaling acts on nearby cells; endocrine signaling involves hormones transported through the bloodstream to distant target cells; synaptic signaling occurs at nerve synapses. Receptors are broadly classified as surface receptors (for hydrophilic ligands that cannot cross the plasma membrane) and intracellular receptors (for lipophilic ligands such as steroid hormones that diffuse across the membrane). Surface receptors include receptor tyrosine kinases (RTKs), G-protein-coupled receptors (GPCRs), and ion channel receptors. RTK activation—triggered by ligand binding and receptor dimerization—leads to autophosphorylation on tyrosine residues, recruiting intracellular signaling proteins and activating cascades such as the RAS-MAPK pathway, which ultimately regulates gene expression and cell division. GPCRs are seven-transmembrane receptors that, upon ligand binding, activate associated G-proteins (trimers of G-alpha, G-beta, G-gamma). The G-alpha subunit exchanges GDP for GTP and dissociates to modulate effectors such as adenylyl cyclase (producing cAMP) or phospholipase C (producing IP3 and DAG), generating second messengers that amplify the signal. Intracellular steroid hormone receptors, once bound to their ligand, translocate to the nucleus and function as transcription factors, directly altering gene expression. This process is slower than surface receptor signaling (hours rather than seconds to minutes) but can produce more lasting changes in cell phenotype. Negative regulation of signaling is critical: protein phosphatases remove phosphate groups added by kinases; GTPase activity (intrinsic to G-alpha) hydrolyzes GTP to GDP to terminate G-protein signaling; receptor internalization and degradation (down-regulation) reduce cell responsiveness to persistent stimulation. Question 47: According to the passage, which type of ligand would most likely use an intracellular receptor?

Reading Comprehension

Question · Easy

Loading more…